Resmed's (ASX:RMD) continuous positive airway pressure (CPAP) devices andmasks treat sleep apnea.
CPAP has long been thegold standard for treating obstructive sleep apnea (OSA), and ResMed is theleading global supplier.
But as of today, ResMed shares have fallen from $40.13 to $23.51,which would be 71% profits for the trade if it recovers back to $40.13.
The sell-off was triggered by disappointing gross margins andgrowing investor concerns about competition from a new wave of GLP-1weight-loss drugs.However, GLP-1 facesseveral headwinds, including supply constraints, lagging real-world efficacy,side effects, low drug compliance, high costs, and a possible lack of insurancecoverage.
Its attractive valuation currently outweighs the risks it faces.This is a great buyingopportunity for me, bought (ASX:RMD) today.
- Forums
- ASX - By Stock
- Buy RMD now and get great upside returns in a year or two
Resmed's (ASX:RMD) continuous positive airway pressure (CPAP)...
-
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$28.42 |
Change
0.085(0.30%) |
Mkt cap ! $17.99B |
Open | High | Low | Value | Volume |
$28.50 | $28.52 | $28.34 | $18.23M | 641.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 169 | $28.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$28.42 | 546 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 195 | 28.420 |
7 | 625 | 28.410 |
13 | 1255 | 28.400 |
7 | 1615 | 28.390 |
2 | 253 | 28.380 |
Price($) | Vol. | No. |
---|---|---|
28.430 | 2188 | 10 |
28.440 | 576 | 4 |
28.450 | 3567 | 7 |
28.460 | 2666 | 6 |
28.470 | 1147 | 3 |
Last trade - 13.34pm 03/07/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online